PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM

This adverse event was reported 7 times

PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MEXILETINE HYDROCHLORIDE 1 0.0024
1 IVOSIDENIB 1 0.0005
2 .ALPHA.1-PROTEINASE INHIBITOR HUMAN 1 0.0003
3 MANNITOL 1 0.0002
4 PYRIDOSTIGMINE BROMIDE 1 0.0001
5 PITAVASTATIN CALCIUM 1 0.0001
6 POSACONAZOLE 1 0.0001
7 ISOSORBIDE DINITRATE 1 0.0001
8 DABRAFENIB 1 0.0000
9 TRAMETINIB 1 0.0000
See all drugs enriched for association with PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM